Skip to Content

Join the 'Plasma-Lyte' group to help and get support from people like you.

Plasma-Lyte News

FDA Medwatch Alert: Baxter IV Solutions: Recall - Potential Presence of Particulate Matter

Posted 5 Jan 2016 by Drugs.com

Includes: 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container 70% Dextrose Injection (2000 mL) USP ISSUE: Baxter International Inc. announced a voluntarily recall of two lots of intravenous (IV) solutions to the hospital/end user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The lots being recalled were distributed to customers and distributors in the United States between June 6, 2015 and December 16, 2015. See the Press Release for affected lot numbers. Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver. There is also the possibility of allergic reactions, ... Read more

Related support groups: Glucose, Sodium Chloride, Dextrose, Normosol-R, Extraneal, Insta-Glucose, Hyper-Sal, Lvp Solution, Dex4, Glutose, Trutol, Polyfusor C, Steriflex No6, Dex4 Gel Tropical Blast, Dex4 Grape, Steriflex No1, Monojel, GlucoBurst, Polyfusor S, Tip-Lok Diluent

FDA Medwatch Alert: Baxter 5 Percent Dextrose Injection, USP And 0.9 Percent Sodium Chloride Injection, USP Intravenous (IV) Solutions: Recall - Particulate Matter In Solution

Posted 27 Dec 2013 by Drugs.com

Product Name Product Code NDC Container Size Lot # Exp. 5% Dextrose Injection, USP 2B0089 0338-0017-38 100 mL P285288 Nov-13 0.9% Sodium Chloride Injection, USP 2B1308 0338-0049-31 50 mL P297283 Aug-14 0.9% Sodium Chloride Injection, USP 2B1302 0338-0049-18 100 mL P292326 Apr-14         P293993 May-14 0.9% Sodium Chloride Injection, USP 2B1309 0338-0049-38 100 mL P293514 Apr-14   [Posted 12/27/2013]  ISSUE: Baxter International Inc. initiated a voluntary recall to the hospital/user level of one lot of 5% Dextrose Injection, USP and four lots of 0.9% Sodium Chloride Injection, USP due to particulate matter found in the solutions. Injecting a product containing particulate matter may result in blockages of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver. There is also the possibility of allergic reactions, local ... Read more

Related support groups: Surgery, Extraneal, Lvp Solution, Normosol-R, Inpersol-LM, Dextrose and Ringer's, Dialyte, Ringer's and Dextrose, Inpersol, Delflex, Plasma-Lyte

FDA Medwatch Alert: Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination

Posted 8 Oct 2012 by Drugs.com

ISSUE: FDA and Hospira announced it is initiating a voluntary user-level recall of one lot of Lactated Ringer’s and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, NDC 0409-7929-09. This action is due to one confirmed customer report where a leak was identified in the primary container between the cobra cap and fill-tube seal and a spore-like structured particulate, consistent with mold, was noted in the solution. When a primary container within an overwrap has a leak, there is an open pathway for contamination of the fluid. The overwrap is not sterile, and any fluid which may have leaked out may become trapped within the overwrap and has the potential to be reintroduced into the primary container. If contaminated solution is used on a patient, critical patient harm may result.  Injections of mold could potentially lead to septicemia (blood stream infections), which in a wo ... Read more

Related support groups: Septicemia, Extraneal, Normosol-R, Lvp Solution, Inpersol-LM, Dextrose and Ringer's, Dialyte, Ringer's and Dextrose, Inpersol, Delflex, Plasma-Lyte

Giving IV Fluids on Scene Might Raise Death Risk for Trauma Victims

Posted 7 Jan 2011 by Drugs.com

THURSDAY, Jan. 6 – The longstanding practice of first giving severely wounded trauma patients intravenous (IV) fluids before bringing them to a trauma center may actually raise their risk of death, a new study suggests. The finding flies in the face of common medical wisdom and mandated protocols in some states that require that IV fluids be given to trauma patients immediately if their blood pressure drops precipitously. But a fresh analysis of data on nearly 777,000 trauma patients revealed that, overall, those who are given pre-hospital IV fluids are actually 11 percent more likely to die than those who aren't, not only because of transport delays but also in part because of the increased risk for bleeding that can accompany a fluid-induced increase in blood pressure. "IV fluid administration to trauma patients pre-hospital is like one of those things that's been thought of as ... Read more

Related support groups: Lvp Solution, Extraneal, Normosol-R, Inpersol, Delflex, Dextrose and Ringer's, Ringer's and Dextrose, Inpersol-LM, Dialyte, Plasma-Lyte

Ask a Question

Further Information

Related Condition Support Groups

Dehydration

Plasma-Lyte Patient Information at Drugs.com